As John Squires makes the bold move to allow patentability of an AI-related invention in Ex parte Desjardins, patent experts ...

26 September 2025 Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and ...

As a US federal shutdown grips IP-critical agencies, layoffs, office closures, and resource cutbacks are underway at the US ...

The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for ...

Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in ...

A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party ...

26 October 2023 Biopharmaceutical patent partner leads team of technical advisors and an associate in California | Partner ...

Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in ...

Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and supply chain risks.

The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug ...